HindustanTimes Thu,18 Dec 2014

Dr Reddy's Lab Q2 profit up 69% at Rs. 690 crore

PTI  New Delhi, October 31, 2013
First Published: 15:30 IST(31/10/2013) | Last Updated: 15:41 IST(31/10/2013)
Drug major Dr Reddy's Laboratories on Thursday reported a 69.41% increase in consolidated net profit at Rs. 690.25 crore for the second quarter ended September 30.

The company had posted a profit of Rs. 407.44 crore in the same period of the previous financial year.
Net sales rose to Rs. 3,357.45 crore from Rs. 2,880.85 crore a year earlier, Dr Reddy's Laboratories said in a BSE filing. Revenue from the global generics segment grew 32% to Rs. 2,654.78 crore, driven by North America, Russia and other emerging markets, the company said.
Shares of Dr Reddy's Laboratories were down 2.52% at Rs. 2,459.20 on the BSE in late afternoon trade.

more from Business

Cabinet okays GST Bill; next stop Parliament

Plans to introduce India’s most ambitious reform initiative, the unified Goods and Services Tax, has entered the final leg, with the Cabinet on Wednesday approving a fresh Constitution Amendment Bill.
Most Popular
Copyright © 2014 HT Media Limited. All Rights Reserved